Compound Detail
CHEMBL160519
PROCATEROL 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL160519 |
| Name | PROCATEROL |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | FKNXQNWAXFXVNW-UHFFFAOYSA-N |
2
Targets
3
Activities
2
Assay Types
0
PK Parameters
20
Publications
2
Known Names
2
Indications
1
Mechanisms
Molecular Properties
290.4
MW (Da)
2.04
ALogP
4
HBA
4
HBD
85.3
PSA (Ų)
0.68
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Beta-2 adrenergic receptor agonist | AGONIST | Beta-2 adrenergic receptor | ✓ | ✓ |
Indications
Asthma Lung Diseases, Obstructive
ATC Classification
R03AC16
procaterol
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03CC08
procaterol
Level 1: RESPIRATORY SYSTEM
Level 2: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Activity Summary
Ki 2 meas. best 7.48
Kd 1 meas. best 7.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 7.48 | 7.48 | 33.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | Kd | 7.1 | 7.1 | 79.4 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 4.07 | 4.07 | 86000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Beta-2 adrenergic receptor | Ki | = | 33.0 | nM | 7.48 | Displacement of [3H]CGP12177 from human beta2 receptor expressed in CHO cells | 27132867 |
| Beta-2 adrenergic receptor | Kd | = | 79.43 | nM | 7.1 | Binding affinity to beta-2 adrenergic receptor (unknown origin) at 1 to 10000 nM | 23954364 |
| D(2) dopamine receptor | Ki | = | 86000.0 | nM | 4.07 | Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells | 27132867 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 894683 | 10.1021/jm00218a024 | Canis familiaris | 8 |
| 6453996 | 10.1021/jm00137a030 | Cavia porcellus | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Cannabinoid receptor 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2A | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | D(1A) dopamine receptor | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-2A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Progesterone receptor | 2 |
| 23984907 | 10.1021/jm400966v | Solute carrier family 22 member 1 | 2 |
| 23984907 | 10.1021/jm400966v | Solute carrier family 22 member 2 | 2 |
| 27132867 | 10.1016/j.bmc.2016.04.028 | D(2) dopamine receptor | 1 |
| 23954364 | 10.1016/j.bmcl.2013.07.052 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine